Number of pages: 100 | Report Format: PDF | Published date: March 20, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
According to the deep-dive market assessment study by Growth Plus Reports, the global pneumatic compression therapy market was valued at US$ 4.2 billion in 2022 and is expected to register a revenue CAGR of 5.5% to reach US$ 6.8 billion by 2031.
Pneumatic Compression Therapy Market Fundamentals
Pneumatic compression therapy is a type of therapy that involves the use of pneumatic compression devices to apply pressure to specific areas of the body. These devices use air pressure to compress and release the affected area, which can help to improve blood flow and reduce swelling. Pneumatic compression therapy is commonly used to treat conditions such as lymphedema, deep vein thrombosis, and venous insufficiency. It is also used to prevent blood clots in patients at risk for developing them, such as those who have undergone surgery or are bedridden. Pneumatic compression therapy involves using inflatable sleeves or stockings worn on the affected limb or area. These sleeves are connected to a pump that inflates and deflates the sleeves, applying pressure to the affected area.
Pneumatic compression pumps are suggested in lymphedema patients who have tried and failed conservative treatments. For individuals with venous ulcers, they are also suggested as an addition to normal therapy. There are different types of pumps; they can be single-chamber (non-segmented) or multi-chambered (segmented), and they can have differing levels of design and complexity. The pressure helps to move fluid out of the affected area and back into the circulatory system. Pneumatic compression therapy is considered safe and effective but may not suit everyone. Patients with certain medical conditions, such as heart failure or high blood pressure, may need to avoid this therapy or use it only under close medical supervision. It is always recommended to consult with a healthcare provider before starting any new treatment.
Pneumatic Compression Therapy Market Dynamics
Pneumatic compression therapy involves devices that inflate and deflate sequentially to promote blood flow in the legs or arms. Several factors drive the global pneumatic compression therapy market. A high-impact driver is a rise in the prevalence of vein disorders, such as leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots. Products, especially stockings, and bandages, are increasingly used to treat the disorders, thus driving the revenue growth of the global pneumatic compression therapy market.
Since hospitalized patients must remain in one position for exceedingly long, venous problems become more common. For instance, despite effective prophylaxis, particularly in patients utilizing helmet CPAP ventilation, upper extremity deep vein thrombosis can occur in COVID-19 patients, according to a study article published in 2022 by the nonprofit American publication PLOS.
During the forecast period, potential advantages of using compression therapy items in treating the target diseases, such as decreased volume in the legs and feet, reduced venous reflux, and low blood pressure, are projected to increase the demand for pneumatic compression devices. Also, the accessibility of many alternatives or modalities, from bandages and stockings to pneumatic devices, to provide effective therapy offers several options for patients with a range of diseases.
The global pneumatic compression therapy market is primarily driven by the rising demand for orthopedic surgeries brought on by an increase in accidents and the world’s obese population. Many orthopedic surgeries result from the growing elderly population’s heightened susceptibility to orthopedic problems. Moreover, a prevalent vein problem in the elderly population is varicose veins. For instance, a study by the Chicago Vein Institute estimates that by 2022, about 50% of Americans over 50 will have varicose veins. These factors are driving demand for pneumatic compression therapy.
Compression clothing is increasingly used in sports medicine, projected to open attractive growth potential for the global market. Compression therapy to reduce swelling and inflammation after trauma or injury is rising. Also, such products are widely used to improve blood flow throughout the body and prevent clotting of fluids in tissue, both of which support muscular health.
However, the lack of public awareness and the availability of alternative management techniques limits the growth of the global pneumatic compression therapy market.
Pneumatic Compression Therapy Market Ecosystem
The global pneumatic compression therapy market has been analyzed from four perspectives: product, technique, application, and region.
Pneumatic Compression Therapy Market by Product
Based on product, the global pneumatic compression therapy market has been segmented into pneumatic compression pumps and pneumatic compression garments.
Pneumatic compression pumps are used to improve circulation and prevent blood clots in patients who are immobile or have limited mobility. These devices work by applying intermittent pressure to the limbs, which helps to increase blood flow and reduce the risk of blood clots. In recent years, there has been growing interest in using pneumatic compression pumps for various conditions, including lymphedema, chronic venous insufficiency, and deep vein thrombosis. This has led to increased demand for these devices in certain markets. Overall, the demand for pneumatic compression pumps is expected to grow in the coming years, driven by an aging population and an increasing focus on preventative care in healthcare.
Pneumatic Compression Therapy Market by Technique
Based on technique, the global pneumatic compression therapy market has been segmented into dynamic compression therapy and static compression therapy.
The static compression therapy segment accounts for the largest revenue share in the global pneumatic compression therapy market. This is a consequence of this technology’s great convenience and user-friendliness. This segment’s significant market share can be attributed to the more widespread availability of these goods for treating edema and sports-related injuries to provide pain and pressure relief. Advantages connected to static technology are thought to influence physicians and patients, making up most of the motivation. As a result of the expanding diabetic and geriatric populations’ increased sensitivity to the development of lymphedema, deep vein thrombosis, and chronic venous insufficiency, this segment is also believed to have a sizable market revenue share.
The dynamic compression therapy segment is projected to observe a high revenue CAGR during the forecast period. This is because the benefits and their impacts make the option a better one going forward. These advantages include external control, strong venous return, and prolonged effect.
Pneumatic Compression Therapy Market by Application
Based on application, the global pneumatic compression therapy market has been segmented into deep vein thrombosis, varicose veins, lymphedema ulcers, and others.
The varicose veins segment accounts for the largest revenue share in the global pneumatic compression therapy market. A varicose vein is a commonly occurring venous disorder. Compression therapy is an effective treatment for varicose veins. Varicose veins are enlarged, twisted veins visible under the skin, usually in the legs. They are caused by weakened or damaged valves that prevent blood from flowing properly through the veins, leading to blood pooling in the affected area.
Pneumatic Compression Therapy Market by Region
Based on region, the global pneumatic compression therapy market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounts for the largest global pneumatic compression therapy market revenue share. The early detection of venous ulcers, arthritis, sports injuries, and patients recovering from automobile accidents are some of the main causes. For instance, according to statistics from the Brain Injury Research Institute from 2021, between 1.6 million and 3.8 million concussions connected to recreation and sports happen annually in the United States. More than 3.5 million injuries occur each year in the United States, where 30 million kids and teens participate in organized sports, according to Sports Injury Data Update 2022. These injuries result in some time lost from involvement. As a result, the increase in sports injuries in this region will result in more use of compression therapy during the recovery of injuries, fueling the revenue growth of the pneumatic compression therapy market.
Asia Pacific is projected to observe a high revenue CAGR during the forecast period. The market is driven by significant R&D expenditures by key competitors and persistent efforts to commercialize goods at a substantially reduced cost. Also, increasing disposable income raises the possibility that these items would be used, and ongoing healthcare infrastructure upgrades are projected to offer the market lucrative growth prospects. Some examples of PCT devices available in the Asia Pacific region include Flowtron® Intermittent Pneumatic Compression System, manufactured by ArjoHuntleigh. This device is designed to help prevent deep vein thrombosis and reduce leg edema. Bio Compression Systems Sequential Circulator 2004 uses sequential pneumatic compression to help improve circulation and reduce limb swelling. It is distributed by Bio Compression Systems, Inc.
Pneumatic Compression Therapy Market Competitive Landscape
The prominent players operating in the global pneumatic compression therapy market are:
Pneumatic Compression Therapy Market Strategic Developments
The global pneumatic compression therapy market is expected to grow at a revenue CAGR of 5.4% during the forecast period.
Stryker Corporation, Spectrum Healthcare, 3 M Company, Medtronic Plc, and Bio Compression Systems, Inc. are among the key players in the global pneumatic compression therapy market.
The dynamic compression therapy segment accounts for the largest revenue share in the global pneumatic compression therapy market.
The increase in the prevalence of deep vein thrombosis, varicose veins, and other chronic diseases augments the demand for compression devices, driving market revenue growth.
The global pneumatic compression therapy market was valued at US$ 4.2 billion in 2022.
*Insights on financial performance are subject to the availability of information in the public domain